Title : Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region.

Pub. Date : 2001 May 15

PMID : 11320450






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 ESBL strains showed high levels of co-resistance to aminoglycosides, tetracycline, trimethoprim-sulfamethoxazole, and ciprofloxacin. Aminoglycosides EsbL Escherichia coli
2 ESBL strains showed high levels of co-resistance to aminoglycosides, tetracycline, trimethoprim-sulfamethoxazole, and ciprofloxacin. Tetracycline EsbL Escherichia coli
3 ESBL strains showed high levels of co-resistance to aminoglycosides, tetracycline, trimethoprim-sulfamethoxazole, and ciprofloxacin. Trimethoprim, Sulfamethoxazole Drug Combination EsbL Escherichia coli
4 ESBL strains showed high levels of co-resistance to aminoglycosides, tetracycline, trimethoprim-sulfamethoxazole, and ciprofloxacin. Ciprofloxacin EsbL Escherichia coli
5 Imipenem remains highly effective against ESBL strains. Imipenem EsbL Escherichia coli